The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Serc 16mg Tablets

16 milligram(s) Tablet

Mylan IRE Healthcare LimitedPA2010/016/002

Main Information

Trade NameSerc 16mg Tablets
Active SubstancesBETAHISTINE HYDROCHLORIDE
Strength16 milligram(s)
Dosage FormTablet
Licence HolderMylan IRE Healthcare Limited
Licence NumberPA2010/016/002

Group Information

ATC CodeN07CA Antivertigo preparations
N07CA01 betahistine

Status

Authorised/WithdrawnAuthorised
Licence Issued15/10/1990
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available

Generics Information

Interchangeable ListBetahistine 16mg Tablets
Interchangeable List CodeIC0084-038-002
Interchangeable List DocumentPDF of Interchangeable List
« Back